Connection

Contact Us
If you have any questions or feedback please contact us.

Search Results to Hunter B Moore

This is a "connection" page, showing the details of why an item matched the keywords from your search.

Search Results

Moore, Hunter

One or more keywords matched the following items that are connected to Moore, Hunter

Item Type	Name
Concept	Plasminogen
Concept	Plasminogen Activator Inhibitor 1
Concept	Urokinase-Type Plasminogen Activator
Concept	Tissue Plasminogen Activator
Academic Article	Fibrinolysis for intermediate-risk pulmonary embolism.
Academic Article	Hemolysis exacerbates hyperfibrinolysis, whereas platelolysis shuts down fibrinolysis: evolving concepts of the spectrum of fibrinolysis in response to severe injury.
Academic Article	Plasma is the physiologic buffer of tissue plasminogen activator-mediated fibrinolysis: rationale for plasma-first resuscitation after life-threatening hemorrhage.
Academic Article	Postinjury fibrinolysis shutdown: Rationale for selective tranexamic acid.
Academic Article	Fibrinolysis shutdown phenotype masks changes in rodent coagulation in tissue injury versus hemorrhagic shock.
Academic Article	Viscoelastic measurements of platelet function, not fibrinogen function, predicts sensitivity to tissue-type plasminogen activator in trauma patients.
Academic Article	Overwhelming tPA release, not PAI-1 degradation, is responsible for hyperfibrinolysis in severely injured trauma patients.
Academic Article	Rationale for the selective administration of tranexamic acid to inhibit fibrinolysis in the severely injured patient.
Academic Article	Freeze-dried plasma enhances clot formation and inhibits fibrinolysis in the presence of tissue plasminogen activator similar to pooled liquid plasma.
Academic Article	Viscoelastic Tissue Plasminogen Activator Challenge Predicts Massive Transfusion in 15 Minutes.
Academic Article	Human neutrophil elastase mediates fibrinolysis shutdown through competitive degradation of plasminogen and generation of angiostatin.
Academic Article	14-Day thawed plasma retains clot enhancing properties and inhibits tPA-induced fibrinolysis.
Academic Article	Thrombin Provokes Degranulation of Platelet a-Granules Leading to the Release of Active Plasminogen Activator Inhibitor-1 (PAI-1).
Academic Article	Fibrinolysis shutdown is associated with a fivefold increase in mortality in trauma patients lacking hypersensitivity to tissue plasminogen activator.
Academic Article	Systemic hyperfibrinolysis after trauma: a pilot study of targeted proteomic analysis of superposed mechanisms in patient plasma.
Academic Article	Thrombin stimulates increased plasminogen activator inhibitor-1 release from liver compared to lung endothelium.
Academic Article	Increase in post-reperfusion sensitivity to tissue plasminogen activator-mediated fibrinolysis during liver transplantation is associated with abnormal metabolic changes and increased blood product utilisation.
Academic Article	Prospective assessment of fibrinolysis in morbid obesity: tissue?plasminogen activator resistance improves after bariatric?surgery.
Academic Article	Clot activators do not expedite the time to predict massive transfusion in trauma patients analyzed with tissue plasminogen activator thrombelastography.
Academic Article	Tissue plasminogen activator (tPA) treatment for COVID-19 associated acute respiratory distress syndrome (ARDS): A case series.
Academic Article	Salvage use of tissue plasminogen activator (tPA) in the setting of acute respiratory distress syndrome (ARDS) due to COVID-19 in the USA: a Markov decision analysis.
Academic Article	The use of thromboelastography to assess post-operative changes in coagulation and predict graft function in renal transplantation.
Academic Article	28-day thawed plasma maintains a2 -antiplasmin levels and inhibits tPA-induced fibrinolysis.
Academic Article	Tranexamic acid mediates proinflammatory and anti-inflammatory signaling via complement C5a regulation in a plasminogen activator-dependent manner.
Academic Article	Computational model of tranexamic acid on urokinase mediated fibrinolysis.
Academic Article	Is there a role for tissue plasminogen activator as a novel treatment for refractory COVID-19 associated acute respiratory distress syndrome?
Academic Article	Plasmin thrombelastography rapidly identifies trauma patients at risk for massive transfusion, mortality, and hyperfibrinolysis: A diagnostic tool to resolve an international debate on tranexamic acid?
Academic Article	Dense and dangerous: The tissue plasminogen activator-resistant fibrinolysis shutdown phenotype is due to abnormal fibrin polymerization.
Academic Article	Rescue therapy for severe COVID-19-associated acute respiratory distress syndrome with tissue plasminogen activator: A case series.
Academic Article	Study of Alteplase for Respiratory Failure in SARS-CoV-2 COVID-19: A Vanguard Multicenter, Rapidly Adaptive, Pragmatic, Randomized Controlled Trial.
Academic Article	MUlticenter STudy of tissue plasminogen activator (alteplase) use in COVID-19 severe respiratory failure (MUST COVID): A?retrospective cohort study.
Academic Article	Plasma-based assays distinguish hyperfibrinolysis and shutdown subgroups in trauma-induced coagulopathy.
Academic Article	Fibrinolysis resistance after liver transplant as a predictor of early infection.
Academic Article	Tissue plasminogen activator resistance is an early predictor of posttraumatic venous thromboembolism: A prospective study from the CLOTT research group.

Search Criteria

Plasminogen